Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nicola Luigi Bragazzi, Andrea Orsi, Filippo Ansaldi, Roberto Gasparini & Giancarlo Icardi. (2016) Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview. Human Vaccines & Immunotherapeutics 12:10, pages 2616-2627.
Read now
Read now
Wan-Ting Huang, Chih-Hsi Chang & Mei-Chen Peng. (2014) Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan. Human Vaccines & Immunotherapeutics 10:1, pages 100-103.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Articles from other publishers (15)
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda & Imran Y. Saleem. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 13:4, pages 455.
Crossref
Crossref
Million A. Tegenge, Linda S. Von Tungeln, Steven A. Anderson, Robert J. Mitkus, Michelle M. Vanlandingham, Richard A. Forshee & Frederick A. Beland. (2019) Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines. Regulatory Toxicology and Pharmacology 108, pages 104436.
Crossref
Crossref
Nikolai Siemens, Sonja Oehmcke-Hecht, Thomas C. Mettenleiter, Bernd Kreikemeyer, Peter Valentin-Weigand & Sven Hammerschmidt. (2017) Port d’Entrée for Respiratory Infections – Does the Influenza A Virus Pave the Way for Bacteria?. Frontiers in Microbiology 8.
Crossref
Crossref
Kinnera E. Chada, Richard Forshee, Hana Golding, Steven Anderson & Hong Yang. (2017) A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines. Vaccine 35:24, pages 3162-3170.
Crossref
Crossref
Million A. Tegenge, Linda S. Von Tungeln, Robert J. Mitkus, Steven A. Anderson, Michelle M. Vanlandingham, Richard A. Forshee & Frederick A. Beland. (2016) Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice. Regulatory Toxicology and Pharmacology 81, pages 113-119.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
259
291
.
Million A. Tegenge & Robert J. Mitkus. (2015) A first-generation physiologically based pharmacokinetic (PBPK) model of alpha-tocopherol in human influenza vaccine adjuvant. Regulatory Toxicology and Pharmacology 71:3, pages 353-364.
Crossref
Crossref
Naru Zhang, Bo-Jian Zheng, Lu Lu, Yusen Zhou, Shibo Jiang & Lanying Du. (2015) Advancements in the development of subunit influenza vaccines. Microbes and Infection 17:2, pages 123-134.
Crossref
Crossref
Rima Khabbaz, Beth P. Bell, Anne Schuchat, Stephen M. Ostroff, Robin Moseley, Alexandra Levitt & James M. Hughes. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
158
177.e6
.
Ruchi R. Shah, Luis A. Brito, Derek T. O’Hagan & Mansoor M. Amiji. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
59
76
.
Sung-Hsi Wei, Ming-Tsan Liu, Yao-Chou Tsai, Chung-Hsin Liao, Chih-Ming Chen, Wei-Yao Wang, Yi-Lung Huang, Feng-Yee Chang & Pesus Chou. (2014) The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study. BMC Infectious Diseases 14:1.
Crossref
Crossref
Nilimesh Halder, Joel K Kelso & George J Milne. (2014) A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness. BMC Infectious Diseases 14:1.
Crossref
Crossref
Markus Hilleringmann, Björn Jobst & Barbara C. Baudner. 2014. Molecular Vaccines. Molecular Vaccines
823
837
.
Million A. Tegenge & Robert J. Mitkus. (2013) A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines. Journal of Pharmacokinetics and Pharmacodynamics 40:5, pages 545-556.
Crossref
Crossref
Matthias Liniger, Artur Summerfield & Nicolas Ruggli. (2012) MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens. PLoS ONE 7:12, pages e49952.
Crossref
Crossref